New approach targets 'Hard-to-Reach' lung spots before surgery
NCT ID NCT04047186
Summary
This small pilot study tested whether giving an immunotherapy drug before surgery could help shrink early-stage lung tumors that appear as multiple, hazy spots (nodules). The goal was to see if this approach could improve the body's immune response against the cancer and potentially reduce the risk of it coming back after surgery. Researchers measured how well the tumors responded to the drug and monitored for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE PULMONARY NODULES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.